Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
KAI Pharmaceuticals
KAI Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Parsabiv
Etelcalcetide
2017-02-07
2030-2034
Secondary hyperparathyroidism
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Etelcalcetide
chronic kidney failure
,
neoplasm metastasis
,
secondary hyperparathyroidism
,
hyperparathyroidism
,
chronic renal insufficiency
,
kidney diseases
,
left ventricular hypertrophy
,
cardiomegaly
,
hypertrophy
Benzocaine
sepsis
,
disseminated intravascular coagulation
,
venous thromboembolism
,
thromboembolism
,
psoriasis
DELCASERTIB
myocardial infarction
,
infarction
,
cardiovascular diseases
,
pathologic processes
Histone-arginine methyltransferase carm1
glaucoma
,
pharmacokinetics
,
acute pain
,
asthma
,
ocular hypertension
,
open-angle glaucoma
,
multiple myeloma
,
plasma cell neoplasms
,
healthy volunteers/patients
,
erectile dysfunction
,
gastrointestinal neoplasms
,
neoplasm metastasis
,
hiv-2
,
renal cell carcinoma
,
neoplasms
,
breast neoplasms
,
lymphoma
,
pancreatic neoplasms
,
triple negative breast neoplasms
,
hypogonadism
,
prostatic neoplasms
,
lung neoplasms
,
sarcoma
,
castration-resistant prostatic neoplasms
,
colorectal neoplasms
,
stomach neoplasms
,
glioblastoma
,
biliary tract neoplasms
,
hypertension
,
uterine cervical neoplasms
,
b-cell lymphoma
,
endometrial neoplasms
,
esophageal neoplasms
,
small cell lung carcinoma
,
transitional cell carcinoma
,
chronic hepatitis
,
liver diseases
,
gastrointestinal diseases
,
virus diseases
,
rna virus infections
,
digestive system diseases
,
viral hepatitis human
,
flaviviridae infections
,
general anesthesia
,
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
,
obstructive sleep apnea
,
sleep apnea syndromes
,
apnea
,
syndrome
,
disorders of excessive somnolence
,
sleepiness
,
papillomavirus infections
,
vaginal neoplasms
,
vulvar neoplasms
,
condylomata acuminata
,
hodgkin disease
,
migraine disorders
,
atherosclerosis
,
uterine neoplasms
,
carcinosarcoma
,
mullerian mixed tumor
,
adenocarcinoma
,
esophageal squamous cell carcinoma
,
large b-cell lymphoma diffuse
,
neuroendocrine tumors
,
intestinal neoplasms
,
head and neck neoplasms
,
prostatic hyperplasia
,
sarcopenia
,
muscular atrophy
,
eunuchism
,
hypertrophy
,
urologic neoplasms
,
hepatocellular carcinoma
,
urinary bladder neoplasms
,
liver neoplasms
,
microsatellite instability
,
hidradenitis suppurativa
,
non-small-cell lung carcinoma
,
chronic hepatitis c
,
type 2 diabetes mellitus
,
diabetes mellitus
,
carcinoma
,
squamous cell carcinoma of head and neck
,
obesity
,
melanoma
,
squamous cell carcinoma
,
vomiting
,
nausea
,
urinary tract infections
,
anesthesia
,
keratoconjunctivitis sicca
,
dry eye syndromes
,
eye diseases
,
overweight
,
polycystic kidney diseases
,
inflammation
,
spondylarthritis
,
spondylitis
,
axial spondyloarthritis
,
neuralgia
,
postherpetic neuralgia
,
hepatitis
,
hepatitis a
,
hepatitis c
,
hiv infections
,
ovarian neoplasms
,
hiv
,
acquired immunodeficiency syndrome
,
infections
,
communicable diseases
,
herpes zoster
,
mumps
,
measles
,
chickenpox
,
rubella
,
kidney diseases
,
rheumatoid arthritis
,
ovarian epithelial carcinoma
,
hepatitis a virus
,
immunosuppression therapy
,
hemorrhage
,
chronic renal insufficiency
,
chronic disease
,
drug-related side effects and adverse reactions
,
non-hodgkin lymphoma
,
follicular lymphoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use